- Federal agenciesRemoves a federal statutory constraint on price discrimination, which supporters say would enable manufacturers and sup…
- ManufacturersReduces regulatory compliance costs and potential litigation exposure associated with Robinson–Patman claims for manufa…
- Potential benefitEnables more flexible pricing arrangements and contracting practices (e.g., tailored discounts, volume-based deals) tha…
Restore Prescription Drugs Discount Act
Read twice and referred to the Committee on the Judiciary.
This bill would repeal the Robinson–Patman Act of 1936 in its entirety. The Robinson–Patman Act is a federal antitrust statute that, among other things, prohibits certain forms of price discrimination by sellers of goods.
Whether repeal primarily benefits consumers via lower negotiated prices (conservative view) or disproportionately benefits large purchasers/intermediaries at the expense of small retailers and some consumers (liberal view).
Relative to its intended legislative type, this bill is legally precise about what is being changed (the repeal of the Robinson-Patman Act) but provides minimal contextual, implementation, fiscal, or oversight detail.
This bill would repeal the Robinson–Patman Act of 1936 in its entirety.
The Robinson–Patman Act is a federal antitrust statute that, among other things, prohibits certain forms of price discrimination by sellers of goods.
Repeal would remove that statutory prohibition and any amendments made by that Act, without adding replacement provisions or regulatory language in this bill text.
On content alone, a straight repeal of a long‑standing antitrust statute is politically and substantively significant despite the bill's brevity. The proposal lacks compromise mechanisms, invites organized opposition from small businesses and consumer advocates, and has uncertain economic effects that would draw scrutiny from regulators and committees. While it could attract powerful industry backers, those factors make enactment unlikely without broader legislative packaging or negotiation.
Relative to its intended legislative type, this bill is legally precise about what is being changed (the repeal of the Robinson-Patman Act) but provides minimal contextual, implementation, fiscal, or oversight detail.
Whether repeal primarily benefits consumers via lower negotiated prices (conservative view) or disproportionately benefits large purchasers/intermediaries at the expense of small retailers and some consumers (liberal view).
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Local governmentsCritics say repeal could enable larger buyers to secure exclusive or deeper discounts that small or independent pharmac…
- ConsumersOpponents argue the change could facilitate discriminatory contracting or exclusionary practices (for example, favored…
- Potential burdenRepeal would eliminate a statutory cause of action specific to price discrimination, which critics say reduces legal re…
Why the argument around this bill splits.
Whether repeal primarily benefits consumers via lower negotiated prices (conservative view) or disproportionately benefits large purchasers/intermediaries at the expense of small retailers and some consumers (liberal vi…
A mainstream liberal/left-leaning observer would likely view this bill with concern.
They would see repeal of Robinson–Patman as removing protections against price discrimination that historically helped small businesses and independent retailers, and worry about downstream harms to small pharmacies, rural providers, and consumers who lack bargaining power.
They would also be skeptical that repeal will automatically lower prescription costs for end users and worry discounts could flow preferentially to large purchasers or intermediaries rather than patients.
A pragmatic moderate would weigh potential pro-competitive flexibility against the risk of hurt small businesses and opaque discounting.
They would note that Robinson–Patman has been less actively enforced in recent decades and that modern competition issues often involve PBMs, insurers, and vertical consolidation rather than simple price discrimination among retailers.
They would likely be open to repeal if accompanied by measures to protect small sellers and to ensure discounts benefit consumers rather than only intermediaries.
A mainstream conservative would generally view the repeal positively as a deregulatory, pro-market move that removes an old restriction on price flexibility.
They are likely to argue that allowing manufacturers to set different prices freely promotes competition, enables negotiated discounts, and could help lower costs for large purchasers and ultimately consumers.
They would typically oppose keeping an economy-wide price-discrimination prohibition that can inhibit innovative contracting and discounts.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, a straight repeal of a long‑standing antitrust statute is politically and substantively significant despite the bill's brevity. The proposal lacks compromise mechanisms, invites organized opposition from small businesses and consumer advocates, and has uncertain economic effects that would draw scrutiny from regulators and committees. While it could attract powerful industry backers, those factors make enactment unlikely without broader legislative packaging or negotiation.
- The bill text provides no cost estimate or analysis of likely economic effects; the magnitude and distribution of impacts on prices, competition, and consumers are therefore unclear.
- Political coalition dynamics are unknown from the text: which industry groups, state officials, or congressional actors would actively support or oppose the repeal, and whether the bill would be offered alone or as part of a larger package.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether repeal primarily benefits consumers via lower negotiated prices (conservative view) or disproportionately benefits large purchasers…
On content alone, a straight repeal of a long‑standing antitrust statute is politically and substantively significant despite the bill's br…
Relative to its intended legislative type, this bill is legally precise about what is being changed (the repeal of the Robinson-Patman Act) but provides minimal contextual, implementation, fiscal, or oversight detail.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.